FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1906409251> ?p ?o ?g. }

• W1906409251 endingPage "7" @default.
• W1906409251 startingPage "551" @default.
• W1906409251 abstract "Ets-1 proto-oncogene is a transcription factor involved in several cellular functions, including the activation of several proteases participating in tumor invasion and metastasis. The objective of this study was to analyze the possible correlation between Ets-1 mRNA expression and survival in advanced-stage ovarian carcinomas, studying two patient groups with extremely different disease outcome. Sections from 66 primary ovarian carcinomas and metastatic lesions from 41 patients diagnosed with advanced-stage ovarian carcinoma (International Federation of Gynecologists and Obstetricians stages III and IV) were evaluated for expression of Ets-1 using mRNA in situ hybridization. Patients were divided into long-term (n = 17) and short-term (n = 24) survivors. The mean values for disease-free survival and overall survival were 116 and 133 months for long-term survivors, as compared to 3 and 21 months for short-term survivors, respectively. Expression of Ets-1 mRNA was detected in carcinoma cells and stromal cells in 28 of 66 (42%) and 22 of 66 (33%) lesions, respectively. Ets-1 expression showed an association with mRNA expression of vascular endothelial growth factor (P = 0.001 for carcinoma cells; P = 0.004 for stromal cells), basic fibroblast growth factor (P = 0.049 for carcinoma cells), and membrane type-1 matrix metalloproteinase (P = 0.045), which were previously studied in this patient cohort. Ets-1 mRNA was detected more often in both carcinoma and stromal cells in tumors of short-term survivors (P = 0.038 for carcinoma cells). In univariate survival analysis for all cases, Ets-1 expression in both tumor (P = 0.018) and stroma (P = 0.026) correlated with poor survival. These findings were reproduced in an analysis of primary tumors alone (P = 0.039 for tumor cells; P < 0.001 for stromal cells). Ets-1 mRNA expression in stromal cells retained its predictive power in a multivariate survival analysis in which all molecules studied previously in this patient cohort were included (P = 0.007). To our knowledge, this is the first evidence associating Ets-1 mRNA expression and poor survival in human epithelial malignancy. Ets-1 is thus a novel prognostic marker in advanced-stage ovarian carcinoma. The association between Ets-1 mRNA expression and the expression of membrane type-1 matrix metalloproteinase and angiogenic genes, first documented here in a study of patient material, points to the central role of this transcription factor in tumor progression in ovarian carcinoma." @default.
• W1906409251 created "2016-06-24" @default.
• W1906409251 creator A5008004523 @default.
• W1906409251 creator A5027887267 @default.
• W1906409251 creator A5030193985 @default.
• W1906409251 creator A5039174090 @default.
• W1906409251 creator A5052581520 @default.
• W1906409251 creator A5075988137 @default.
• W1906409251 creator A5077653892 @default.
• W1906409251 creator A5078288814 @default.
• W1906409251 creator A5079790031 @default.
• W1906409251 date "2001-03-01" @default.
• W1906409251 modified "2023-10-02" @default.
• W1906409251 title "Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma." @default.
• W1906409251 cites W103495436 @default.
• W1906409251 cites W140013419 @default.
• W1906409251 cites W1457049491 @default.
• W1906409251 cites W1523597610 @default.
• W1906409251 cites W1829804413 @default.
• W1906409251 cites W1976831807 @default.
• W1906409251 cites W1981486175 @default.
• W1906409251 cites W1992743577 @default.
• W1906409251 cites W2004702770 @default.
• W1906409251 cites W2018950363 @default.
• W1906409251 cites W2038808630 @default.
• W1906409251 cites W2039772820 @default.
• W1906409251 cites W2069837541 @default.
• W1906409251 cites W2076692692 @default.
• W1906409251 cites W2082985735 @default.
• W1906409251 cites W2091433021 @default.
• W1906409251 cites W2091548699 @default.
• W1906409251 cites W2106787323 @default.
• W1906409251 cites W2120789358 @default.
• W1906409251 cites W2133013402 @default.
• W1906409251 cites W225647261 @default.
• W1906409251 cites W2395492951 @default.
• W1906409251 cites W2406430560 @default.
• W1906409251 cites W2415663988 @default.
• W1906409251 cites W2419676527 @default.
• W1906409251 cites W3202124643 @default.
• W1906409251 cites W38397700 @default.
• W1906409251 cites W54165365 @default.
• W1906409251 cites W2395333464 @default.
• W1906409251 cites W2413216272 @default.
• W1906409251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11297247" @default.
• W1906409251 hasPublicationYear "2001" @default.
• W1906409251 type Work @default.
• W1906409251 sameAs 1906409251 @default.
• W1906409251 citedByCount "34" @default.
• W1906409251 countsByYear W19064092512012 @default.
• W1906409251 countsByYear W19064092512014 @default.
• W1906409251 countsByYear W19064092512015 @default.
• W1906409251 countsByYear W19064092512016 @default.
• W1906409251 countsByYear W19064092512017 @default.
• W1906409251 countsByYear W19064092512018 @default.
• W1906409251 countsByYear W19064092512020 @default.
• W1906409251 countsByYear W19064092512022 @default.
• W1906409251 countsByYear W19064092512023 @default.
• W1906409251 crossrefType "journal-article" @default.
• W1906409251 hasAuthorship W1906409251A5008004523 @default.
• W1906409251 hasAuthorship W1906409251A5027887267 @default.
• W1906409251 hasAuthorship W1906409251A5030193985 @default.
• W1906409251 hasAuthorship W1906409251A5039174090 @default.
• W1906409251 hasAuthorship W1906409251A5052581520 @default.
• W1906409251 hasAuthorship W1906409251A5075988137 @default.
• W1906409251 hasAuthorship W1906409251A5077653892 @default.
• W1906409251 hasAuthorship W1906409251A5078288814 @default.
• W1906409251 hasAuthorship W1906409251A5079790031 @default.
• W1906409251 hasConcept C121608353 @default.
• W1906409251 hasConcept C126322002 @default.
• W1906409251 hasConcept C142724271 @default.
• W1906409251 hasConcept C143998085 @default.
• W1906409251 hasConcept C144301174 @default.
• W1906409251 hasConcept C16930146 @default.
• W1906409251 hasConcept C2777546739 @default.
• W1906409251 hasConcept C2779013556 @default.
• W1906409251 hasConcept C2780427987 @default.
• W1906409251 hasConcept C2781018059 @default.
• W1906409251 hasConcept C29537977 @default.
• W1906409251 hasConcept C3019054536 @default.
• W1906409251 hasConcept C38180746 @default.
• W1906409251 hasConcept C502942594 @default.
• W1906409251 hasConcept C71924100 @default.
• W1906409251 hasConcept C86803240 @default.
• W1906409251 hasConceptScore W1906409251C121608353 @default.
• W1906409251 hasConceptScore W1906409251C126322002 @default.
• W1906409251 hasConceptScore W1906409251C142724271 @default.
• W1906409251 hasConceptScore W1906409251C143998085 @default.
• W1906409251 hasConceptScore W1906409251C144301174 @default.
• W1906409251 hasConceptScore W1906409251C16930146 @default.
• W1906409251 hasConceptScore W1906409251C2777546739 @default.
• W1906409251 hasConceptScore W1906409251C2779013556 @default.
• W1906409251 hasConceptScore W1906409251C2780427987 @default.
• W1906409251 hasConceptScore W1906409251C2781018059 @default.
• W1906409251 hasConceptScore W1906409251C29537977 @default.
• W1906409251 hasConceptScore W1906409251C3019054536 @default.
• W1906409251 hasConceptScore W1906409251C38180746 @default.
• W1906409251 hasConceptScore W1906409251C502942594 @default.

• next